IL2 and neoplasm: The enhanced killing phenotype of the NK-92 line is partially explained by the fact the cells are activated with IL-2 and they lack or have lower expression of various NK inhibitory receptors, thus reducing the ability of the target tumour cells to suppress them [19,23,39].